IOVANCE BIOTHERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $3.19 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-08-06
- 2020-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $3.19M.
- 2020-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $5.21M.
- 2019-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $7.82M.
- 2019-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.46M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2020-06-30 | $3.19M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $5.21M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $7.82M 10-K · filed 2020-02-25 |
| 2019-09-30 | $2.46M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $4.32M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $5.04M 10-Q · filed 2019-05-07 |
| 2016-09-30 | $610.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $610.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $114.00K 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |